This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Il Dong Pharmaceutical Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Jooyun Lee: Innovator in CFTR Modulation
Introduction
Jooyun Lee is a prominent inventor based in Hwaseong, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate the cystic fibrosis transmembrane conductance regulator (CFTR). His work is crucial for advancing treatments for various diseases.
Latest Patents
Jooyun Lee holds a patent for "Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators." This patent provides CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds, which can be utilized in treating eye diseases and CFTR-related indications. The compounds described in the patent offer methods for modulating CFTR functionality and inhibiting PDE4 in biological systems.
Career Highlights
Jooyun Lee is associated with Il Dong Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has led to advancements in the treatment of inflammatory diseases and disorders, showcasing his commitment to improving patient outcomes.
Collaborations
He collaborates with notable colleagues, including Jongmin Yoon and Ilji Jeong, who contribute to his research and development efforts. Their teamwork enhances the potential for groundbreaking discoveries in their field.
Conclusion
Jooyun Lee's contributions to CFTR modulation and his innovative approach to pharmaceutical development highlight his importance in the industry. His work not only advances scientific knowledge but also has the potential to improve the lives of many patients.